Two phase 3 RCTs (STEP1 and STEP 2) regarding overweight or obese patients with diabetes mellitus, proved that semaglutide 2.4mg subcutaneously weekly was superior to placebo, as far as body-weight reduction is concerned, 41,42 while similar results were derived from another phase 3 trial, comparing oral semaglutide with liraglutide in diabetic overweight patients, where semaglutide achieved significantly greater weight reduction than liraglutide or placebo (NCT02863419-PIONEER 4)
When taking oral semaglutide, it is essential to follow the fasting window closely and avoid rich foods early in the day to minimize stomach upset
Body Composition Changes in Patients on GLP-1 Receptor Agonists Undergoing an Intensive Cardiac Rehabilitation Program
The study included about 3,500 participants and was conducted in 28 countries involving around 400 investigator sites
Even the best time to take L-carnitine wont deliver benefits unless you take it regularly and combine it with proper nutrition and training
The result is mild water retention that shows up as puffiness in the hands, feet, or face